Graham is business turnaround and growth specialist who has over 10 years’ experience running companies, transforming them from an idea to commercial success. During the pandemic, he saw a ...

Graham leads Aviation Week's coverage of technology, focusing on engineering and technology across the aerospace industry, with a special focus on identifying technologies of strategic importance ...

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...

In a transformative donation, the Clark Art Institute in Williamstown, Massachusetts, has received a gift from the Aso O. Tavitian Foundation of 331 works of art. The fact that the Imperial War Museum ...

France’s Genfit has said its elafibranor drug as a treatment for non-alcoholic steatohepatitis (NASH) was unable to improve patient outcomes in a phase 3 study, which has now been terminated.

Intercept Pharma’s obeticholic acid (OCA) – trying to become the first FDA-approved therapy for non-alcoholic steatohepatitis (NASH) – will come under scrutiny by FDA advisors before the ...

The deal adds to a rapidly-expanding pipeline of NASH candidates at Novo Nordisk, which also includes GLP-1 analogue semaglutide in phase 3 in combination with drugs from Gilead, a long-acting ...

Annely Juda Fine Art will be moving to 16 Hanover Square in the autumn of 2025, after 35 years on nearby Dering Street. The earth itself is fertile artistic ground at Somerset House — but the ...

BUFFALO, N.Y. — There's no shortage of places to find music, but sometimes it can be tough to keep track of which artists are coming to Western New York. That's why 2 On Your Side will keep ...

Products Market Alerts MyCollection Price Database Become a Partner Gallery ...